• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪酸和氧化固醇的协同作用会损害线粒体功能,并限制非酒精性脂肪性肝病进展过程中的肝脏适应能力。

Synergistic interaction of fatty acids and oxysterols impairs mitochondrial function and limits liver adaptation during nafld progression.

机构信息

C.U.R.E. University Centre for Liver Disease Research and Treatment, Institute of Internal Medicine, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.

C.U.R.E. University Centre for Liver Disease Research and Treatment, Institute of Internal Medicine, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy; Institute of Neurology, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.

出版信息

Redox Biol. 2018 May;15:86-96. doi: 10.1016/j.redox.2017.11.016. Epub 2017 Dec 5.

DOI:10.1016/j.redox.2017.11.016
PMID:29220698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5725223/
Abstract

The complete mechanism accounting for the progression from simple steatosis to steatohepatitis in nonalcoholic fatty liver disease (NAFLD) has not been elucidated. Lipotoxicity refers to cellular injury caused by hepatic free fatty acids (FFAs) and cholesterol accumulation. Excess cholesterol autoxidizes to oxysterols during oxidative stress conditions. We hypothesize that interaction of FAs and cholesterol derivatives may primarily impair mitochondrial function and affect biogenesis adaptation during NAFLD progression. We demonstrated that the accumulation of specific non-enzymatic oxysterols in the liver of animals fed high-fat+high-cholesterol diet induces mitochondrial damage and depletion of proteins of the respiratory chain complexes. When tested in vitro, 5α-cholestane-3β,5,6β-triol (triol) combined to FFAs was able to reduce respiration in isolated liver mitochondria, induced apoptosis in primary hepatocytes, and down-regulated transcription factors involved in mitochondrial biogenesis. Finally, a lower protein content in the mitochondrial respiratory chain complexes was observed in human non-alcoholic steatohepatitis. In conclusion, hepatic accumulation of FFAs and non-enzymatic oxysterols synergistically facilitates development and progression of NAFLD by impairing mitochondrial function, energy balance and biogenesis adaptation to chronic injury.

摘要

导致非酒精性脂肪性肝病 (NAFLD) 从单纯性脂肪变性进展为脂肪性肝炎的完整机制尚未阐明。脂毒性是指肝内游离脂肪酸 (FFA) 和胆固醇积聚引起的细胞损伤。在氧化应激条件下,过量的胆固醇会自动氧化为氧化固醇。我们假设 FFA 和胆固醇衍生物的相互作用可能主要损害线粒体功能,并影响 NAFLD 进展过程中的生物发生适应。我们证明,在给予高脂肪+高胆固醇饮食的动物肝脏中,特定的非酶性氧化固醇的积累会诱导线粒体损伤和呼吸链复合物蛋白的耗竭。在体外测试时,5α-胆甾烷-3β,5,6β-三醇(三醇)与 FFA 结合能够降低分离的肝线粒体的呼吸作用,诱导原代肝细胞凋亡,并下调参与线粒体生物发生的转录因子。最后,在人类非酒精性脂肪性肝炎中观察到线粒体呼吸链复合物的蛋白质含量较低。总之,肝内 FFA 和非酶性氧化固醇的积累通过损害线粒体功能、能量平衡和对慢性损伤的生物发生适应,协同促进 NAFLD 的发生和发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556f/5725223/30f77984d52b/mmc4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556f/5725223/8b452e50757c/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556f/5725223/5e018540b6e4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556f/5725223/7d9ef096b099/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556f/5725223/a04373bf057b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556f/5725223/065555e73764/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556f/5725223/c50632c5c44c/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556f/5725223/4ed8c264273b/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556f/5725223/9aa3de819001/mmc1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556f/5725223/ba15a471ff2a/mmc2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556f/5725223/b7e0742990e3/mmc3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556f/5725223/30f77984d52b/mmc4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556f/5725223/8b452e50757c/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556f/5725223/5e018540b6e4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556f/5725223/7d9ef096b099/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556f/5725223/a04373bf057b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556f/5725223/065555e73764/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556f/5725223/c50632c5c44c/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556f/5725223/4ed8c264273b/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556f/5725223/9aa3de819001/mmc1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556f/5725223/ba15a471ff2a/mmc2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556f/5725223/b7e0742990e3/mmc3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/556f/5725223/30f77984d52b/mmc4.jpg

相似文献

1
Synergistic interaction of fatty acids and oxysterols impairs mitochondrial function and limits liver adaptation during nafld progression.脂肪酸和氧化固醇的协同作用会损害线粒体功能,并限制非酒精性脂肪性肝病进展过程中的肝脏适应能力。
Redox Biol. 2018 May;15:86-96. doi: 10.1016/j.redox.2017.11.016. Epub 2017 Dec 5.
2
Effects of dietary fatty acids and cholesterol excess on liver injury: A lipidomic approach.膳食脂肪酸和胆固醇过量对肝损伤的影响:一种脂质组学方法。
Redox Biol. 2016 Oct;9:296-305. doi: 10.1016/j.redox.2016.09.002. Epub 2016 Sep 9.
3
Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis.非酒精性脂肪性肝炎发病机制中的脂质氧化产物。
Free Radic Biol Med. 2017 Oct;111:173-185. doi: 10.1016/j.freeradbiomed.2017.01.023. Epub 2017 Jan 18.
4
Oxysterols induce mitochondrial impairment and hepatocellular toxicity in non-alcoholic fatty liver disease.氧化甾醇在非酒精性脂肪性肝病中诱导线粒体损伤和肝细胞毒性。
Free Radic Biol Med. 2014 Oct;75 Suppl 1:S16-7. doi: 10.1016/j.freeradbiomed.2014.10.594. Epub 2014 Dec 10.
5
Oxysterols in the orchestra of liver cell metabolism.肝脏细胞代谢中的氧化甾醇。
Free Radic Biol Med. 2014 Oct;75 Suppl 1:S6. doi: 10.1016/j.freeradbiomed.2014.10.838. Epub 2014 Dec 10.
6
Cholesterol burden in the liver induces mitochondrial dynamic changes and resistance to apoptosis.肝脏中的胆固醇负担会引起线粒体动态变化和抗细胞凋亡。
J Cell Physiol. 2019 May;234(5):7213-7223. doi: 10.1002/jcp.27474. Epub 2018 Sep 21.
7
The PDE5 inhibitor udenafil ameliorates nonalcoholic fatty liver disease by improving mitochondrial function.PDE5 抑制剂乌地那非通过改善线粒体功能改善非酒精性脂肪性肝病。
Biochem Biophys Res Commun. 2021 Jun 18;558:57-63. doi: 10.1016/j.bbrc.2021.04.038. Epub 2021 Apr 22.
8
Dihydromyricetin Ameliorates Nonalcoholic Fatty Liver Disease by Improving Mitochondrial Respiratory Capacity and Redox Homeostasis Through Modulation of SIRT3 Signaling.二氢杨梅素通过调节 SIRT3 信号改善线粒体呼吸能力和氧化还原稳态来改善非酒精性脂肪性肝病。
Antioxid Redox Signal. 2019 Jan 10;30(2):163-183. doi: 10.1089/ars.2017.7172. Epub 2018 Feb 21.
9
Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病
Adv Exp Med Biol. 2017;960:443-467. doi: 10.1007/978-3-319-48382-5_19.
10
Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.原花青素 B2 通过调节 TFEB 介导线粒体途径和氧化还原状态改善游离脂肪酸诱导的肝脂肪变性。
Free Radic Biol Med. 2018 Oct;126:269-286. doi: 10.1016/j.freeradbiomed.2018.08.024. Epub 2018 Aug 22.

引用本文的文献

1
Cholic acid as a treatment for cerebrotendinous xanthomatosis: a comprehensive review of safety and efficacy.胆酸治疗脑腱黄瘤病:安全性和有效性的全面综述
Orphanet J Rare Dis. 2025 Jul 29;20(1):387. doi: 10.1186/s13023-025-03889-9.
2
Epithelial barrier hypothesis in the context of nutrition, microbial dysbiosis, and immune dysregulation in metabolic dysfunction-associated steatotic liver.代谢功能障碍相关脂肪性肝病中营养、微生物群失调和免疫失调背景下的上皮屏障假说
Front Immunol. 2025 May 14;16:1575770. doi: 10.3389/fimmu.2025.1575770. eCollection 2025.
3
MTFR2-Mediated Fission Drives Fatty Acid and Mitochondrial Co-Transfer from Hepatic Stellate Cells to Tumor Cells Fueling Oncogenesis.

本文引用的文献

1
Ezetimibe reduced hepatic steatosis induced by dietary oxysterols in nonhuman primates.依折麦布可减轻非人灵长类动物因膳食氧化甾醇诱导的肝脂肪变性。
FEBS Open Bio. 2016 Sep 20;6(10):1008-1015. doi: 10.1002/2211-5463.12107. eCollection 2016 Oct.
2
Effects of dietary fatty acids and cholesterol excess on liver injury: A lipidomic approach.膳食脂肪酸和胆固醇过量对肝损伤的影响:一种脂质组学方法。
Redox Biol. 2016 Oct;9:296-305. doi: 10.1016/j.redox.2016.09.002. Epub 2016 Sep 9.
3
Mitochondrial dysfunctions in 7-ketocholesterol-treated 158N oligodendrocytes without or with α-tocopherol: Impacts on the cellular profil of tricarboxylic cycle-associated organic acids, long chain saturated and unsaturated fatty acids, oxysterols, cholesterol and cholesterol precursors.
MTFR2介导的裂变驱动脂肪酸和线粒体从肝星状细胞向肿瘤细胞的共同转移,从而促进肿瘤发生。
Adv Sci (Weinh). 2025 Jun;12(23):e2416419. doi: 10.1002/advs.202416419. Epub 2025 May 14.
4
Placenta nanoparticle treatment in guinea pigs mitigates FGR-associated fetal sex-dependent effects on liver metabolism-related signaling pathways.豚鼠胎盘纳米颗粒治疗可减轻与胎儿生长受限相关的、对肝脏代谢相关信号通路的胎儿性别依赖性影响。
Am J Physiol Endocrinol Metab. 2025 Mar 1;328(3):E395-E409. doi: 10.1152/ajpendo.00440.2024. Epub 2025 Feb 5.
5
Dietary Influences on Gut Microbiota and Their Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).饮食对肠道微生物群的影响及其在代谢功能障碍相关脂肪性肝病(MASLD)中的作用
Nutrients. 2024 Dec 31;17(1):143. doi: 10.3390/nu17010143.
6
Paradoxes: Cholesterol and Hypoxia in Preeclampsia.悖论:子痫前期中的胆固醇和缺氧。
Biomolecules. 2024 Jun 13;14(6):691. doi: 10.3390/biom14060691.
7
Monocyte bioenergetics: An immunometabolic perspective in metabolic dysfunction-associated steatohepatitis.单核细胞生物能量学:代谢功能障碍相关脂肪性肝炎的免疫代谢观点。
Cell Rep Med. 2024 May 21;5(5):101564. doi: 10.1016/j.xcrm.2024.101564. Epub 2024 May 10.
8
Cholestane-3β,5α,6β-triol Induces Multiple Cell Death in A549 Cells via ER Stress and Autophagy Activation.胆甾烷-3β,5α,6β-三醇通过内质网应激和自噬激活诱导 A549 细胞发生多种细胞死亡。
Mar Drugs. 2024 Apr 13;22(4):174. doi: 10.3390/md22040174.
9
Imbalance of mitochondrial fusion in peripheral blood mononuclear cells is associated with liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis.外周血单个核细胞中线粒体融合失衡与代谢功能障碍相关脂肪性肝炎患者的肝纤维化有关。
Heliyon. 2024 Mar 8;10(6):e27557. doi: 10.1016/j.heliyon.2024.e27557. eCollection 2024 Mar 30.
10
Effect of -Derived Antigens on Nonalcoholic Fatty Liver Disease Induced by High-Fat Diet in Mice.源自 - 的抗原对高脂饮食诱导的小鼠非酒精性脂肪性肝病的影响。
ACS Pharmacol Transl Sci. 2024 Jan 18;7(2):432-444. doi: 10.1021/acsptsci.3c00276. eCollection 2024 Feb 9.
7-酮胆固醇处理的158N少突胶质细胞中有无α-生育酚时的线粒体功能障碍:对三羧酸循环相关有机酸、长链饱和与不饱和脂肪酸、氧化甾醇、胆固醇及胆固醇前体细胞谱的影响。
J Steroid Biochem Mol Biol. 2017 May;169:96-110. doi: 10.1016/j.jsbmb.2016.03.029. Epub 2016 Mar 25.
4
Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis.非酒精性脂肪肝患者的肝线粒体功能适应在脂肪性肝炎中丧失。
Cell Metab. 2015 May 5;21(5):739-46. doi: 10.1016/j.cmet.2015.04.004.
5
Molecular pathways in non-alcoholic fatty liver disease.非酒精性脂肪性肝病中的分子途径
Clin Exp Gastroenterol. 2014 Jul 5;7:221-39. doi: 10.2147/CEG.S62831. eCollection 2014.
6
Mitochondrial-nuclear genome interactions in non-alcoholic fatty liver disease in mice.线粒体-核基因组相互作用在小鼠非酒精性脂肪性肝病中的作用。
Biochem J. 2014 Jul 15;461(2):223-32. doi: 10.1042/BJ20131433.
7
The Influence of an Obesogenic Diet on Oxysterol Metabolism in C57BL/6J Mice.致肥胖饮食对C57BL/6J小鼠氧化甾醇代谢的影响
Cholesterol. 2014;2014:843468. doi: 10.1155/2014/843468. Epub 2014 Feb 5.
8
Implications of cholesterol autoxidation products in the pathogenesis of inflammatory diseases.胆固醇自氧化产物在炎症性疾病发病机制中的意义。
Biochem Biophys Res Commun. 2014 Apr 11;446(3):702-8. doi: 10.1016/j.bbrc.2013.12.107. Epub 2014 Jan 9.
9
Liver adapts mitochondrial function to insulin resistant and diabetic states in mice.肝脏使线粒体功能适应于胰岛素抵抗和糖尿病状态的小鼠。
J Hepatol. 2014 Apr;60(4):816-23. doi: 10.1016/j.jhep.2013.11.020. Epub 2013 Nov 28.
10
Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH).多种打击,包括氧化应激,作为非酒精性脂肪性肝炎(NASH)的发病机制和治疗靶点。
Int J Mol Sci. 2013 Oct 15;14(10):20704-28. doi: 10.3390/ijms141020704.